GARBUJO STEFANIA

Banfi, A., Garbujo, S., Prosperi, D., Colombo, M. (2026). Biomimetic responsive antigen-delivery vehicles for therapeutic and preventive vaccines against hereditary triple-negative breast cancer. Intervento presentato a: BtBs day 2026, Milano, Italy. Dettaglio

Barbieri, L., Salvioni, L., Banfi, A., Garbujo, S., Fiandra, L., Baioni, C., et al. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. ACS APPLIED MATERIALS & INTERFACES, 17(23), 33648-33663 [10.1021/acsami.5c06626]. Dettaglio

Giustra, M., Novati, B., Barbieri, L., Palomer, M., Testa, F., Salvioni, L., et al. (2025). Dual-Modality Detection of Intracellular Nanoparticles via Smart Polymer-Enhanced SERS and Hyperspectral Microscopy Detection. ADVANCED OPTICAL MATERIALS, 13(32) [10.1002/adom.202501881]. Dettaglio

Morelli, L., Ochoa, E., Salvioni, L., Davide Giustra, M., De Santes, B., Spena, F., et al. (2024). Microfluidic nanoparticle synthesis for oral solid dosage forms: A step toward clinical transition processes. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 652(5 March 2024) [10.1016/j.ijpharm.2024.123850]. Dettaglio

Di Miceli, N., Baioni, C., Barbieri, L., Danielli, D., Sala, E., Salvioni, L., et al. (2024). TGF-β Signaling Loop in Pancreatic Ductal Adenocarcinoma Activates Fibroblasts and Increases Tumor Cell Aggressiveness. CANCERS, 16(21) [10.3390/cancers16213705]. Dettaglio